Literature DB >> 4156484

The cardiovascular effects of intraventricular clonidine and Bay 1470 in conscious hypertensive cats.

L Finch.   

Abstract

1 Intraventricular administration of clonidine (5-30 mug) and an analogue, BAY 1470 (15-30 mug) to conscious renal hypertensive cats produced a fall in mean blood pressure lasting for approximately 3 hours. This fall in blood pressure was accompanied by a marked bradycardia.2 Pretreatment with intraventricular phentolamine (100-200 mug), piperoxan (40-200 mug) or tolazoline (75-200 mug) abolished the cardiovascular effects of intraventricular clonidine (20 mug).3 The cardiovascular effects of intraventricular clonidine (20 mug) were not modified by the pretreatment with either haloperidol (1 mg/kg i.p.) or desmethylimipramine (1 mg/kg i.p.).4 Emesis was observed 1-2 min after the administration of either clonidine (5-20 mug) or BAY 1470 (30 mug). This preceded the cardiovascular actions and was still seen after pretreatment with haloperidol, desmethylimipramine, phentolamine, piperoxan or tolazoline.5 It is concluded that the centrally mediated cardiovascular responses observed after intraventricular administration of small doses of clonidine are due to stimulation of central alpha-adrenoceptors and are independent of central catecholamine uptake mechanisms and dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4156484      PMCID: PMC1777044     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  Evidence for an alpha-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane.

Authors:  H Schmitt; S Fenard
Journal:  Eur J Pharmacol       Date:  1971       Impact factor: 4.432

2.  An improved valve device for the continuous measurement of arterial blood pressure in the conscious unrestrained cat.

Authors:  M D Day; R L Whiting
Journal:  J Pharm Pharmacol       Date:  1972-03       Impact factor: 3.765

3.  Desmethylimipramine and the hypotensive action of clonidine in the rabbit.

Authors:  J L Reid; R H Briant; C T Dollery
Journal:  Life Sci I       Date:  1973-05-15

4.  Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HCl.

Authors:  W Kobinger; A Walland
Journal:  Eur J Pharmacol       Date:  1967-12       Impact factor: 4.432

5.  Pharmacological studies on the hypotensive effects of clonidine.

Authors:  P Bolme; K Fuxe
Journal:  Eur J Pharmacol       Date:  1971-01       Impact factor: 4.432

6.  Inhibition of adrenergic neurotransmission by clonidine: an action on prejunctional -receptors.

Authors:  K Starke; K P Altmann
Journal:  Neuropharmacology       Date:  1973-04       Impact factor: 5.250

7.  Construction and implantation of a permanent cannula for making injections into the lateral ventricle of the rat brain.

Authors:  J F Hayden; L R Johnson; R P Maickel
Journal:  Life Sci       Date:  1966-08       Impact factor: 5.037

8.  Sleep produced by clonidine (2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride).

Authors:  R B Holman; E E Shillito; M Vogt
Journal:  Br J Pharmacol       Date:  1971-12       Impact factor: 8.739

9.  Central noradrenergic neurones and the cardiovascular actions of clonidine in the rabbit.

Authors:  C T Dollery; J L Reid
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

10.  [Pressor and depressor action of BAY 1470 (2-(2,6-Xylidino)-5,6-dihydro-4H-1,3-thiazinehydrochloride) as a consequence of its -receptor-stimulating properties].

Authors:  A Heise; G Kroneberg; K Schlossmann
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971
View more
  12 in total

1.  Proceedings: A centrally-acting antihypertensive agent R28935, a pimozide analogue, not acting via alpha-adrenergic neurones.

Authors:  L Finch
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Cardiovascular responses to centrally administered adrenaline in spontaneous hypertensive rats [proceedings].

Authors:  K R Borkowski; L Finch
Journal:  Br J Pharmacol       Date:  1977-09       Impact factor: 8.739

3.  Multiple receptor responses: a new concept to describe the relationship between pharmacological effects and pharmacokinetics of a drug: studies on clonidine in the rat and cat.

Authors:  L K Paalzow; P O Edlund
Journal:  J Pharmacokinet Biopharm       Date:  1979-10

4.  The effect of alpha-adrenoceptor antagonists and metiamide on clonidine-induced locomotor stimulation in the infant rat.

Authors:  Y Nomura; T Segawa
Journal:  Br J Pharmacol       Date:  1979-08       Impact factor: 8.739

5.  Hypotensive and sedative effects of alpha-adrenoceptor agonists: relationship to alpha 1- and alpha 2-adrenoceptor potency.

Authors:  D P Clough; R Hatton
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

6.  Influence of 6-hydroxydopamine on the behavioral effects induced by apomorphine or clonidine in rats.

Authors:  Z S Herman; R Brus; A Drybański; R Szkilnik; J Slomińska-Zurek
Journal:  Psychopharmacology (Berl)       Date:  1976-10-20       Impact factor: 4.530

7.  Tolmesoxide, a drug that lowers blood pressure by a direct relaxant effect on vascular smooth muscle.

Authors:  J C Doxey
Journal:  Br J Pharmacol       Date:  1978-05       Impact factor: 8.739

8.  Effects of clonidine on habituation and sensitization of acoustic startle in normal, decerebrate and locus coeruleus lesioned rats.

Authors:  M Davis; J M Cedarbaum; G K Aghajanian; D S Gendelman
Journal:  Psychopharmacology (Berl)       Date:  1977-03-16       Impact factor: 4.530

9.  Evidence for a peripheral component in the sympatholytic effect of clonidine in rats.

Authors:  M J Brown; D Harland
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

10.  Oral clonidine premedication reduces vomiting in children after strabismus surgery.

Authors:  K Mikawa; K Nishina; N Maekawa; M Asano; H Obara
Journal:  Can J Anaesth       Date:  1995-11       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.